Novartis to Up Lek Bid by almost 50 Euros
Basel, 18 October - The Swiss pharma company Novartis said Friday it was willing to raise its offer for the takeover of Slovenian drug maker Lek to SIT 105,000 (EUR 459). The largest shareholders agree to sell all Lek shares at the price, and fully back the merger of Lek and Novartis's division Novartis Generics.
The rest of this news item is available to subscribers.
The news item consists of 385 characters (without spaces) or 70 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.